EUVIMEDEUVIMED entdecken
Crossref

Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver

Ahmed Awad iD, Koustav Pal iD, Steven Yevich, Joshua D Kuban, Alda Tam, Bruno C Odisio, Sanjay Gupta, Peiman Habibollahi, Andrew J Bishop iD, Anthony Paul Conley, Neeta Somaiah iD, Dejka M Araujo und 6 weitere

Cancer · 2024-08 · 130 (15) · 2703-2712

DOI: 10.1002/cncr.35330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 20.04.2024. Verfasst von Ahmed Awad und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Liver Neoplasms, Sarcoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate outcomes following percutaneous image‐guided ablation of soft tissue sarcoma metastases to the liver. Materials and Methods A single‐institution retrospective analysis of patients with a diagnosis of metastatic soft tissue sarcoma who underwent percutaneous image‐guided ablation of hepatic metastases between January 2011 and December 2021 was performed. Patients with less than 60 days of follow‐up after ablation were excluded. The primary outcome was local tumor progression‐free survival (LPFS). Secondary outcomes included overall survival, liver‐specific progression‐free survival. and chemotherapy‐free survival.

Results

Fifty‐five patients who underwent percutaneous ablation for 84 metastatic liver lesions were included. The most common histopathological subtypes were leiomyosarcoma (23/55), followed by gastrointestinal stromal tumor (22/55). The median treated liver lesions was 2 (range, 1–8), whereas the median size of metastases were 1.8 cm (0.3–8.7 cm). Complete response at 2 months was achieved in 90.5% of the treated lesions. LPFS was 83% at 1 year and 80% at 2 years. Liver‐specific progression‐free survival was 66% at 1 year and 40% at 2 years. The overall survival at 1 and 2 years was 98% and 94%. The chemotherapy‐free holiday from the start of ablation was 71.2% at 12 months. The complication rate was 3.6% (2/55); one of the complications was Common Terminology Criteria for Adverse Events grade 3 or higher. LPFS subgroup analysis for leiomyosarcoma versus gastrointestinal stromal tumor suggests histology‐agnostic outcomes (2 years, 89% vs 82%, p = .35).

Conclusion

Percutaneous image‐guided liver ablation of soft tissue sarcoma metastases is safe and efficacious.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsSarcomaHumansFemaleMaleMiddle AgedAgedRetrospective StudiesAdultAged, 80 and overLeiomyosarcomaTreatment OutcomeProgression-Free SurvivalGastrointestinal Stromal TumorsCatheter Ablation

Stichwörter der Autor:innen

ablation techniquehepaticinterventional radiologymetastasessoft tissue sarcomasurvival

Autor:innen und Institutionen

  • Department of Interventional Radiology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Ahmed Awad, Koustav Pal, Andrew J Bishop, Neeta Somaiah, Christina L Roland, Emily Z Keung, Rahul A Sheth

Zitieren

APA

Awad, A., Pal, K., Yevich, S., Kuban, J. D., Tam, A., Odisio, B. C., Gupta, S., Habibollahi, P., Bishop, A. J., Conley, A. P., Somaiah, N., Araujo, D. M., Zarzour, M. A., Ratan, R., Roland, C. L., Keung, E. Z., Huang, S. Y., & Sheth, R. A. (2024). Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver. Cancer, 130(15), 2703-2712. https://doi.org/10.1002/cncr.35330

Vancouver

Awad A, Pal K, Yevich S, Kuban JD, Tam A, Odisio BC, et al. Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver. Cancer. 2024;130(15):2703-2712. doi:10.1002/cncr.35330

BibTeX
@article{Awad2024,
  author = {Awad, Ahmed and Pal, Koustav and Yevich, Steven and Kuban, Joshua D and Tam, Alda and Odisio, Bruno C and Gupta, Sanjay and Habibollahi, Peiman and Bishop, Andrew J and Conley, Anthony Paul and Somaiah, Neeta and Araujo, Dejka M and Zarzour, Maria Alejandra and Ratan, Ravin and Roland, Christina L and Keung, Emily Z and Huang, Steven Y and Sheth, Rahul A},
  title = {Safety and efficacy of percutaneous image‐guided ablation for soft tissue sarcoma metastases to the liver},
  journal = {Cancer},
  year = {2024},
  volume = {130},
  number = {15},
  pages = {2703--2712},
  doi = {10.1002/cncr.35330}
}
Kostenlos starten →